Erythropoietin Stimulating Agents Market Size to Reach USD 16.81 Billion by 2033, Driven by Rising chronic kidney disease and Chemotherapy-Induced Anemia Cases – SNS Insider
Growing chronic disease burden, expanding biosimilar adoption, and hospital-led demand support steady market expansion. Austin, Texas, Jan. 16, 2026 (GLOBE…